Topic: Galectin-3 and Apheresis: The Future of Medicine
Listen to integrative medicine pioneer and Galectin-3 expert Dr. Isaac Eliaz, MD, for an in-depth discussion where he will share breakthrough research and clinical pearls in the management of culprit biomarker, Galectin-3.
Medical professionals are increasingly aware of Galectin-3’s pathogenic role as an upstream driver of today’s most critical health conditions — sepsis, Alzheimer’s disease, metastatic cancer, autoimmune disease, environmental illness, and much more. Concurrently, a fast-growing body of data underscores the first-line clinical validity of targeting Galectin-3 and its pathogenic activity with novel treatments, including selective plasma filtration apheresis and biochemical Galectin-3 inhibition.
In this webinar, Dr. Eliaz presents groundbreaking research findings and practice-tested protocols to effectively manage Galectin-3, including the use of selective apheresis showing breakthrough results against life-threatening sepsis and other pro-inflammatory conditions. He will also discuss benefits, risks, and common misconceptions related to apheresis.
Learning objectives:
- The latest research on Galectin-3 as a key pathogenic driver in life-threatening and chronic diseases, premature aging, and other areas of health
- Understanding apheresis and total plasma exchange: separating the evidence from myths, avoiding common pitfalls; guidelines for successful use of apheresis in clinical practice
- Evidence-based strategies for apheresis application and Galectin-3 management
About the host:
Isaac Eliaz, MD, MS, LAc, is a physician-scientist, clinician, and recognized leading expert in the field of Galectin-3 and therapeutic apheresis. Dr. Eliaz has advanced therapeutic apheresis treatment for more than 15 years, and he has been researching Galectin-3 for over three decades. He has authored multiple peer-reviewed publications on Galectin-3, and has received NIH grant support for research into Galectin-3 and apheresis. Dr. Eliaz has followed apheresis patients for over a decade at Amitabha Medical Clinic, implementing a systems-based, integrative care model across diverse patient populations. For Dr. Eliaz’s full CV, click here.
